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Background: Dual anti-platelet therapy (DAPT: Aspirin + Thienopyridine) is a cornerstone of treatment for patients who present with acute 
coronary syndromes (ACS), and in patients undergoing percutaneous coronary intervention (PCI). Current guidelines call for prolonged DAPT for all 
pts undergoing PCI with a drug-eluting stent (DES), and shorter duration (≥ 1 month) for all pts receiving a bare metal stent (BMS). While premature 
discontinuation of DAPT has been associated with an increased risk of stent thrombosis in previous studies, real-world patterns of adherence to 
DAPT prescription have not been characterized in detail, nor has relationship of DAPT non-adherence to other clinical outcomes been established.
Methods: The PARIS (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients) registry is a multi-center, multinational, prospective 
observational study that will follow subjects for 24 months after stent implantation, and will examine the features of non-adherence to DAPT 
following stenting.
Results: Among 5033 subjects, the mean age was 64 years, 74.5% were male, 40.9% presented with ACS, and 82% received a drug-eluting stent.
37.6% of subjects were on DAPT pre-procedure, and 99.6% were on DAPT at the time of discharge. At 30 days, the overall incidence of non-
adherence was 2.1% (104 subjects, 147 episodes): disruption 69%, interruption 19%, and discontinuation 12%. Stent thrombosis (probable and 
definite per ARC definitions) was rare at 0.46%. Of the 26 pts with ST, 17 were definite ST, and 9 were probable ST. The rate of ST in adherent 
population was 0.46% (23/4929), compared to 2.9% (3/104) amongst the non-adherent group (OR: 6.3; 95% CI [1.9-21.4]). To date all pts have 
completed 6 month follow-up and all results including adjudicated adverse events will be presented.
Conclusion: In this real-world population of patients undergoing PCI with stent implantation, non-adherence to DAPT was low at 30 days. While the 
rate of ST at 30 days was low (0.46%), there was a strong association between non-adherence and ST. Complete 6 month data will be presented.
